National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2010 specification under subsection 84AAA(2) (No. PB 53 of 2010) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 53 of 2010
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2010 - Specification Under Subsection 84AAA(2)
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
I, Felicity McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 20 May 2010
FELICITY MCNEILL
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — Pharmaceutical Benefits - Early Supply
1 Name of Instrument
(1) This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2010 - specification under subsection 84AAA(2).
(2) This Instrument may also be cited as “No. PB 53 of 2010”.
2 Commencement
This Instrument commences on 1 June 2010.
3 Amendment of PB 30 of 2009
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.
Schedule 1 Amendments
Schedule 1, after item dealing with Alendronic acid with colecalciferol
insert in the columns in the order indicated:
| Alendronic acid with colecalciferol and calcium | Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) | Oral | 1 | 5 |
Schedule 1, item dealing with Clopidogrel
insert in the columns in the order indicated:
| Tablet 75 mg (as besilate) | Oral | 28 | 5 |
Schedule 1, item dealing with Mesalazine
insert in the columns in the order indicated:
| Tablet 1.2 g (prolonged release) | Oral | 60 | 5 |
Schedule 1, after item dealing with Perindopril
insert in the columns in the order indicated:
| Perindopril with amlodipine | Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate) | Oral | 30 | 5 |
| Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate) | Oral | 30 | 5 | |
| Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate) | Oral | 30 | 5 | |
| Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate) | Oral | 30 | 5 |
0
0
0